---
title: Horizon’s iPSC cell line engineering services
description: Horizon can help researchers work with the biologically relevant cell models (immune cells, induced pluripotent derived cardiac and neural cells, and organoids) that closely mimic the end-stage biology of interest. With over a decade of CRISPR/Cas cell line engineering experience, Horizon’s iPSC editing platform enables efficient and precise genomic modifications in a wide variety of organisms and tissues.
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![thumbnail\_shutterstock\_1009156630](https://info.edifydigitalmedia.com/hs-fs/hubfs/thumbnail_shutterstock_1009156630.jpg?width=1280&name=thumbnail_shutterstock_1009156630.jpg "thumbnail_shutterstock_1009156630")

**Horizon’s iPSC cell line engineering services**

 

 

 

 

*Brought to you by* 

*![HD\_Logo\_111x111\_RGB\_72dpi](https://info.edifydigitalmedia.com/hs-fs/hubfs/HD_Logo_111x111_RGB_72dpi.jpg?width=111&name=HD_Logo_111x111_RGB_72dpi.jpg)*

---

 

![Poster\_189x189](https://info.edifydigitalmedia.com/hubfs/Poster_189x189.jpg "Poster_189x189")

The development of therapeutic treatments is a challenging process linked to understanding mechanisms that underly human disorders. Finding the relevant biological model has been a limiting process so far. The development of induced pluripotent stem cell (iPSC) technology has revolutionized the way we study complex disorders. iPSCs offer a unique in vitro platform for generating large quantities of cells for disease modeling, drug screening, and ultimately cell-based therapy. By combining such a platform with CRISPR-Cas9 gene editing technology, Horizon unlocks the potential to produce engineered iPSCs for a wide range of tissues and diseases.

Leveraging more than a decade of cell line engineering experience and with its optimal workflows, Horizon is able to deploy a highly efficient and highly scalable iPSC gene-editing platform to offer a wide range of cell line engineering services ranging from:

- Gene knockout
- Single nucleotide polymorphism (SNP) or point mutations
- Fluorescent reporter cell lines
- Inducible gene expression

Here, we demonstrate Horizon’s efficient gene editing platform and capabilities to edit complex pluripotent stem cells for disease modeling.

 

### Download the Poster

## Copyright 2020 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions